Optic nerve glioma epidemiology and demographics

Revision as of 14:45, 6 October 2015 by Simrat Sarai (talk | contribs)
Jump to navigation Jump to search

Optic nerve glioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Optic nerve glioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Optic nerve glioma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Optic nerve glioma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Optic nerve glioma epidemiology and demographics

CDC on Optic nerve glioma epidemiology and demographics

Optic nerve glioma epidemiology and demographics in the news

Blogs on Optic nerve glioma epidemiology and demographics

Directions to Hospitals Treating Optic nerve glioma

Risk calculators and risk factors for Optic nerve glioma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

There is no racial predilection to the optic nerve glioma.[1] Optic nerve gliomas affects girls and boys equally.

Epidemiology and Demographics

Optic nerve gliomas typically present in children, and often in the setting of NF1 (10-63%). In this setting, the tumors are often low grade and indolent. In adults, optic nerve gliomas do occur but are very rare and usually aggressive tumors. In such cases no association with NF1 has been found.[2] 5 % of all childhood brain tumors account for optic nerve gliomas. About 1% of all intracranial tumors are comprised of optic-nerve gliomas.[3] It is most common in children who have the genetic condition neurofibromatosis 1 (NF1).

Incidence

The incidence of NF-1 among patients of optic nerve glioma is 10-70% and the incidence of optic nerve glioma in patients with NF-1 varies from 8 to 31 %.[4]

Gender

Boys and girls are equally affected.

Age

The mean age of presentation of optic nerve glioma is 8.8 years. Most optic gliomas occur in children, are slow-growing and noncancerous and almost always occur before age 20. 90 percent of optic nerve gliomas are diagnosed before the age of 20. 75 percent of optic nerve gliomas are diagnosed before the age of 10, 50 percent before the age of 5 and 25 percent before the age of 18 months.[5] The mean age of presentation of optic nerve gliomas is 8.8 years.[2]

Age of onset of optic nerve glioma Percentage of optic nerve glioma diagnosed
20

90%

10

75%

5

50

18 months

25

Race

There are no racial or ethnic groups that are at more risk than others of optic nerve gliomas.

References

  1. Optic nerve glioma. Radiopedia(2015) http://radiopaedia.org/articles/optic-nerve-glioma Accessed on October 2 2015
  2. 2.0 2.1 Optic glioma. Medline Plus(2015) https://www.nlm.nih.gov/medlineplus/ency/article/001024.htm Accessed on October 5 2015
  3. Dutton JJ (1994). "Gliomas of the anterior visual pathway". Surv Ophthalmol. 38 (5): 427–52. PMID 8009427.
  4. Nair AG, Pathak RS, Iyer VR, Gandhi RA (2014). [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi? dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24736941 "Optic nerve glioma: an update"] Check |url= value (help). Int Ophthalmol. 34 (4): 999–1005. doi:10.1007/s10792-014-9942-8. PMID 24736941. line feed character in |url= at position 54 (help)
  5. Alvord EC, Lofton S (1988). "Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment". J Neurosurg. 68 (1): 85–98. doi:10.3171/jns.1988.68.1.0085. PMID 3275755.

Template:WH Template:WS